Journal Article Summary
The article discusses the concept of "aspirin resistance," which refers to patients who do not show the expected benefits of aspirin therapy in reducing the risk of vascular diseases. This topic is significant because aspirin is widely used to prevent further complications in individuals with existing vascular conditions, and understanding why some patients do not respond as expected can help improve treatment outcomes. The author argues that many patients labeled as "aspirin resistant" are actually noncompliant with their medication regimen, which can lead to an increased risk of future vascular events.
In the review, the author examines various studies that highlight the issue of noncompliance among patients who initially show an inadequate response to aspirin. It was found that when these patients are retested under conditions ensuring they have taken the medication, their platelet function often returns to normal, indicating that the problem may not be true resistance to the drug. The article suggests that instead of labeling these patients as "aspirin resistant," it is more accurate to refer to them as having an "inadequate response to aspirin," emphasizing the importance of adherence to the medication.
The article acknowledges limitations in the current understanding of aspirin response and the need for better methods to assess and improve patient compliance. It highlights the potential for developing simple, quick tests to evaluate aspirin's effectiveness in real-time, which could help identify patients at risk for future vascular events. Patients are encouraged to discuss their aspirin use and any concerns about its effectiveness with their healthcare providers to ensure they are taking the medication correctly and to explore strategies for improving adherence.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Schwartz Kenneth A.. Aspirin Resistance. The Neurohospitalist 2011. DOI: 10.1177/1941875210395776. PMID: 23983843. PMCID: PMC3726079.
Featured Pill Pals Product
OTC 1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
